Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Sampling In "Spotlight" Of Boston Grand Jury As Part Of TAP Investigation

Executive Summary

Pharmaceutical companies should consider how their sampling programs will look in "the very bright spotlight of a federal grand jury investigation," Boston Assistant U.S. Attorney Michael Loucks said during the Food & Drug Law Institute annual meeting April 19 in Washington, D.C.

You may also be interested in...



PBM Subpoenas Piling Up; AdvancePCS Notes Firms Are Good Source Of Data

The Boston U.S. Attorney's Office subpoenas to pharmacy benefit managers reflect the position of PBMs as the best source of data on pharmaceutical use and pricing, AdvancePCS said

PBM Subpoenas Piling Up; AdvancePCS Notes Firms Are Good Source Of Data

The Boston U.S. Attorney's Office subpoenas to pharmacy benefit managers reflect the position of PBMs as the best source of data on pharmaceutical use and pricing, AdvancePCS said

AstraZeneca Zoladex Marketing Practices Under Investigation By DoJ

A Department of Justice investigation into AstraZeneca's Zoladex marketing practices is continuing following the recent settlement with TAP over Lupron.

Related Content

UsernamePublicRestriction

Register

PS037716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel